In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price target of...
Stock Comparison Tools FAANG Stocks Gold ETFs Cash Equivalents Big Bank Stocks Big Pharma Stocks Retail Stocks Top Indexes Dow Jones S&P 500 Nasdaq Gold Bitcoin Market Outlook Today's Market US Economy Gold & Precious Metals Commodities Forex Editors' Picks Cryptocurrency Market Data Bond ETFs Commodi...
GlaxoSmithKline has an analyst consensus of Hold, with a price target consensus of p1,617.50, representing a 19.86% upside. In a report released yesterday, Deutsche Bank also maintained a Hold rating on the stock with a £13.50 price target. See today’s best-performing stocks on TipRanks ...
The screener displaysprobability calculations based on the delayed stock price at the time the strategy is updated.The new day's options data will start populating the screener at approximately 8:55a CT. Strikes that have not traded today are excluded from the results. ...
*Stock Advisor returns as of November 20, 2020 Iain Mackay--Chief Financial Officer Good morning, and good afternoon. Thank you for joining us for our full-year 2020 results, which were issued earlier today. Normally, Sarah Elton-Farr, our Director of IR would lead this call but unfortunate...
healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs cash equivalents big bank stocks big pharma stocks retail stocks top indexes dow jones s&p 500 nasdaq gold bitcoin market outlook today's market us economy gold & precious metals commodities forex...
The Affordable Care Act, or Obamacare, is an individual mandate that requires all eligible Americans to have some form of basic health coverage. For tax years prior to 2019, those without insurance will receive a penalty when they file their tax returns
*Stock Advisor returns as of January 31, 2019 Our speakers today are Chief Executive Officer, Emma Walmsley; Simon Dingemans, Chief Financial Officer; and Dr. Hal Barron, Chief Scientific Officer and President of R&D. We have a broader team available for Q&A. ...
*Stock Advisor returns as of June 7, 2021 Iain Mackay--Chief Financial Officer Good morning and good afternoon. Thank you for joining us for our second quarter 2021 results, which were issued earlier today. You should have received our press release and can view the presentation on GSK's we...
and no plans to initiate any positions within the next 72 hours.I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in t...